Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.verified

ALXN

Price:

$182.5

Market Cap:

$0

Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS (eculizumab), a monoclonal antibody for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It also provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. In addition, the company is developing ALXN12...[Read more]

Industry

Biotechnology

IPO Date

1996-02-01

Stock Exchange

NASDAQ

Ticker

ALXN

The PE Ratio as of December 2025 (TTM) for Alexion Pharmaceuticals, Inc. (ALXN) is 59.23

According to Alexion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 59.23. This represents a change of 591.81% compared to the average of 8.56 of the last 4 quarters.

Alexion Pharmaceuticals, Inc. (ALXN) Historical PE Ratio (quarterly & annually)

How has ALXN PE Ratio performed in the past?

The mean historical PE Ratio of Alexion Pharmaceuticals, Inc. over the last ten years is 106.29. The current 59.23 PE Ratio has changed 5.47% with respect to the historical average. Over the past ten years (40 quarters), ALXN's PE Ratio was at its highest in in the December 2017 quarter at 220.33. The PE Ratio was at its lowest in in the December 2013 quarter at -343.60.

Quarterly (TTM)
Annual

Average

106.29

Median

69.38

Minimum

10.11

Maximum

281.97

Alexion Pharmaceuticals, Inc. (ALXN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alexion Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 461.04%

Maximum Annual PE Ratio = 281.97

Minimum Annual Increase = -96.41%

Minimum Annual PE Ratio = 10.11

Quarterly (TTM)
Annual
YearPE RatioChange
202056.73461.04%
201910.11-96.41%
2018281.67366.32%
201760.40-12.06%
201668.69-75.64%
2015281.97405.33%
201455.80-45.69%
2013102.7446.64%
201270.06-6.24%
201174.720.82%

Alexion Pharmaceuticals, Inc. (ALXN) Average PE Ratio

How has ALXN PE Ratio performed in the past?

The current PE Ratio of Alexion Pharmaceuticals, Inc. (ALXN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

116.17

5-year avg

95.52

10-year avg

106.29

Alexion Pharmaceuticals, Inc. (ALXN) PE Ratio vs. Peers

How is ALXN’s PE Ratio compared to its peers?

Alexion Pharmaceuticals, Inc.’s PE Ratio is greater than Seagen Inc. (-69.22), greater than Ambrx Biopharma Inc. (-13.86), less than Odonate Therapeutics, Inc. (3.23K), greater than La Jolla Pharmaceutical Company (10.76), greater than Niagen Bioscience Inc (29.19), greater than Roivant Sciences Ltd. (-40.23), less than Takara Bio Inc. (163.26), greater than Arena Pharmaceuticals, Inc. (-8.82), greater than EQRx, Inc. (5.40), greater than POINT Biopharma Global Inc. (12.03),

Build a custom stock screener for Alexion Pharmaceuticals, Inc. (ALXN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alexion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alexion Pharmaceuticals, Inc. (ALXN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alexion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Alexion Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Alexion Pharmaceuticals, Inc. (ALXN)?

What is the highest PE Ratio for Alexion Pharmaceuticals, Inc. (ALXN)?

What is the 3-year average PE Ratio for Alexion Pharmaceuticals, Inc. (ALXN)?

What is the 5-year average PE Ratio for Alexion Pharmaceuticals, Inc. (ALXN)?

How does the current PE Ratio for Alexion Pharmaceuticals, Inc. (ALXN) compare to its historical average?